Colon Cancer Alliance and Chris4Life Colon Cancer Foundation Merge Organizations
Colon Cancer Alliance + Chris4Life Colon Cancer Foundation = Chemistry
So much chemistry, that we’ve merged—forming an unbreakable bond to better serve you! The Colon Cancer Alliance has a long-standing credible reputation and Chris4Life is known for its creative and personal mission.Together, we will accelerate a joint mission where more people will be screened for this unique cancer and where more patients and survivors are supported so they can live longer, better lives. This will be done by advancing research, screening and patient support programs.
Merger Details
The merger of the Colon Cancer Alliance and the Chris4Life Colon Cancer Foundation creates the nation’s largest colon cancer specific nonprofit. Maintaining the Colon Cancer Alliance name and headquarters in Washington, D.C., this unified organization will have increased resources to advance colorectal cancer research, expand patient empowerment programs and save lives through bigger and better screening campaigns. This strategic alliance gives a larger presence to the colon cancer community where we will continue to serve and represent the patient voice.
The specifics of the merger will continue to evolve and we’ll keep our community and supporters up-to-date.
Commonly Asked Questions
- When is the merger official?
- The merger is legally official as of January 1, 2016.
- Who is going to be the CEO of new combined organization?
- Michael Sapienza, CEO of the Chris4Life Colon Cancer Foundation, will become the new CEO of the Colon Cancer Alliance. Eric Hargis, current CEO of the Colon Cancer Alliance, will oversee and support the organization throughout the merger and continue with the organization in a management consultant role.
- Are other executive leadership changes happening?
- Jasmine Greenamyer, current Chief Operations Officer of the Colon Cancer Alliance will transition into a Chief Strategy & Program Officer position. Marti Stiteler, current Chief Operations Officer of the Chris4Life Colon Cancer Foundation will transition into Chief Finance and Technology Officer of the Colon Cancer Alliance.
- Is the Chris4Life Colon Cancer Foundation name going away?
- The Chris4Life Colon Cancer Foundation name will continue to live on as a fund at the Colon Cancer Alliance specifically dedicated to research.
Will any programs and services be impacted by the merger?
- As a unified organization, both teams are committed to high quality programs and services that support patients and survivors while also expanding prevention efforts. All programs and events inherent to both Colon Cancer Alliance and Chris4Life Colon Cancer Foundation will run in parallel throughout 2016.
- Where can I find more information about both organizations?
- For more information about the organizations, please visit:
For more information contact us.
Top resources
Alliance Names Kate Watt Chief Development Officer
Watt’s extensive experience in building fundraising strategies and teams will help advance the Alliance's mission to end the disease.
FDA Clears Way for Colorectal Cancer Clinical Trial Led by Dr. Christopher Lieu
The U.S. Food and Drug Administration has given researchers at the University of Colorado Anschutz Medical Campus permission to begin a clinical trial of CAR T-cell therapy for people with advanced colorectal cancer who have already tried the standard treatments without lasting success.
He almost skipped the colonoscopy that saved his life
Andy said his lifestyle made it easier to ignore the blood in the stool, a symptom of colorectal cancer. But the “mirage of invincibility,” as he called it, was about to vanish.